Use of warfarin during pregnancy

Canadian Family Physician

Volumn 48, Issue APRIL., 2002, Pages 695-697

  Abadi, Shirin ^a   Einarson, Adrienne ^a   Koren, Gideon ^a,b  

^a Motherisk Program   (Canada)

^b CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; BLEEDING; BLOOD PLACENTA BARRIER; CLINICAL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DELIVERY; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EXPOSURE; DRUG MEGADOSE; DRUG USE; EMBRYOPATHY; FEMALE; FETUS RISK; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; NEWBORN; PREGNANCY; PROPHYLAXIS; RISK FACTOR; TERATOGENICITY;

ANTICOAGULANTS; FEMALE; FETUS; HEPARIN; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; VENOUS THROMBOSIS; WARFARIN;

EID: 0036099685     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Compendium of pharmaceuticals and specialties
2. The warfarin embryopathy: A rat model showing maxillonasal hypoplasia and other skeletal disturbances
3. Warfarin-induced fetal abnormalities
4. Pregnancy in patients with prosthetic heart valves: The effects of anticoagulation on mother, fetus, and neonate
5. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prosthesis
6. Anticoagulation during pregnancy
7. Warfarin embryopathy and urinary tract anomalies: Possible new association
8. Maternal and fetal sequelae of anticoagulation during pregnancy
9. Pregnancy in patients with prosthetic heart valves
10. Follow-up study of children whose mothers were treated with warfarin during pregnancy
11. The problem of cardiac valve prostheses, anticoagulants, and pregnancy
12. Pregnancy and its complications after cardiac valve replacement
13. Pregnancy in patients with mechanical prosthetic heart valves
14. Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valve
15. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves
16. Outcome of pregnancy in women with valve prostheses
17. Use of antithrombotic agents during pregnancy
18. Retrospective evaluation of the safety and efficacy of low-molecular-weight heparin as thromboprophylaxis during pregnancy